The deal priced below last closing price of $42.97. JPMorgan, Goldman Sachs and Evercore ISI are acting as joint book running managers for the offering.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERA:
- Vera Therapeutics Advances Atacicept with Promising Trial Results
- Vera Therapeutics announces $300M offering of Class A common stock
- Vera Therapeutics files automatic mixed securities shelf
- Vera Therapeutics price target raised to $64 from $56 at Guggenheim
- Disney initiated, Cisco upgraded: Wall Street’s top analyst calls